We combine high tech scientific R&D with long term practice and science-based knowledge.
Innovative science of data analytics allows cross species mapping of disease symptoms to their mechanistical biology, enabling careful selection of the most optimal plants and/or constituents for medicine development.

We are committed to demonstrating the efficacy and safety of plant-based substances with advanced, animal-friendly research techniques. In this, we cherish Collaborative Relationships and our Patient Registry, an exclusive and growing patient registry of over 20,000 patients aids in scientific research related to their medical conditions.
Additionally, we value our relationships with patient organizations and professional associations.

Utilizing plants as a source for medicines and innovative artificial intelligence, we aim to design fit-for-purpose, sustainable and affordable drugs for the future. This approach reflects our commitment to ethical practices and environmental consciousness.
BioGntx is acting on the largest opportunity with regards to the development of plant-based medicines, as it targets the identification of synergistic plant based medicines which has proven to be more potent than synthetically optimized pharmacological drugs.

We focus on Unmet Medical Needs: BioGntx targets specific medical conditions with substantial unmet needs, including Coeliac disease, Noonan syndrome, immune-mediated neuropsychiatric disorders, and mitochondrial disease.